Clinical Update on Alzheimer's Disease: Managed Care Perspectives
Activity Date: April 2007  — Activity Info: Volume4, (4)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

To provide managed care pharmacists, VA pharmacists, and Department of Defense pharmacists with up-to-date information regarding their role in the treatment of patients with Alzheimer’s disease.

This activity is designed for managed care pharmacists, VA pharmacists, and Department of Defense pharmacists. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Review the pathophysiology and manifestations of Alzheimer’s disease (AD).
  • Assess the efficacy of currently available therapies and the potential of treatments that are still in development.
  • Understand the rationale for combining pharmacologic and behavioral therapies to lessen the burden of AD on patients and their caregivers.
  • Recognize the impact of AD in the managed care setting and formulate a strategy to optimize patient and health systems outcomes.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council of Pharmacy Education (ACPE) to provide continuing education for pharmacists.

This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE program # 064-000-06-206-H01

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean of Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity: 2 hours.

Release date: April 15, 2007. Expiration date: April 15, 2009.

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications,
contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or cosponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written
statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from Forest Research Institute.
Home | Contact Us | View Account | Need Help?